In order to understand
the specific function of the Xist RNA, one must first have an appreciation
for the biological pathway in which Xist operates. Xist is part of the
Mammalian Dosage Compensation system. This pathway has evolved to maintain
gene dose equality between the heterogametic sexes during development. Thus:
|
Dosage Compensation ::
A mechanism that
senses gene dosage and regulates gene expression in relation to the
perceived dose. In mammals there is monoallelic expression of X-linked
genes that differ in dose between females (XX) and males (XY) |
Here is the Eureka!
moment: Mary Lyons proposed a startling hypothesis in 1961: as the dosage
compensation pathway has evolved to maintain gene dose equity between the
heterogametic sexes, and in mammals the female embryo has twice as many
copies of X-linked genes as the male, Could the dosage compensation pathway
alter the expression of genes in females to create functional equivalence
between males and females in terms of expression of X-linked genes? If this
hypothesis is true, it would imply that all mammalian females are
functionally mosaic for X-linked gene expression.
Over
the years since Mary Lyon's hypothesis, a number of experiments have
demonstrated its validity.
One of the most
surprising observations was the discovery of the Xist RNA. The Xist RNA is a
large non-coding RNA which has been shown to necessary for developmentally
regulated chromosomal silencing in females.
The Xist RNA is
quite larger (18 kb), is not translated, it is spliced, and polyadenylated.
It is also organized into blocks of repetitive sequence. In the following
diagram one can see four blocks (A, B, C, D) of repetitive sequence in the
Xist RNA. This diagram was generated using a dot matrix program. The murine
Xist RNA was compared against itself using a window of 20 bases and whenever
17/20 bases were the same a dot was recorded.
One
of the most remarkable qualities exhibited by the Xist RNA is that it can be
found to be stably associated with the silenced X chromosome. Forming an
Xist body. Ectopic expression of the Xist RNA demonstrates that Xist can
form a body with any (and every) chromosome from which it is expressed. In
fact, the expression of Xist RNA is always CIS-limited.

The Xist body is
always one of the two X-chromosomes in mammalian females, and it is always
"silent" in terms of X-linked gene expression.
Xist
expression constructs have been designed and constructed. They can be used
in stem cells as well as in whole animal experiments to confer CIS-linked
silencing.
Deletion
analysis has revealed that the A-region of Xist has a very important (but
uncharacterized) role in function.
Single deletions of the B, C, D regions do not prevent the binding of the
Xist RNA in CIS to a chromosome. However, using
PNA interference mapping, or P-IMP, PNA oligomers directed at the C-region can
block the association of the Xist RNA with the X-chromosome.
When Xist binding is
inhibited by PNA, the Xist RNA is still found within the cell. Despite the
presence of normal levels of the RNA, no silencing occurs. Thus the binding
of the RNA is essential for its function. |